Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ProShares UltraShort Nasdaq Biotechnology (BIS)

32.92
Delayed Data
As of Aug 26
 -0.52 / -1.56%
Today’s Change
27.07
Today|||52-Week Range
54.01
+14.66%
Year-to-Date

Investment Objective

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index . The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.

No recent news for ProShares UltraShort Nasdaq Biotechnology.

Performance

1 month-4.86% 3 years-39.11%
3 months-12.91% 5 years-48.56%
1 year+3.33% Since inception-43.04%
Data through 08/27/2016

Quote Details

Previous close$33.44
Open day’s range32.31 – 33.58
Net asset value (NAV)32.91 (08/26/2016)
Daily volume512,374
Average volume (3 months)273,705
Data as of 3:59pm ET, 08/26/2016

Peer Comparisonvs. Trading--inverse equity ETFs

 BISCategory
Performance 5-yr return-48.56%-30.54%
Expense Gross exp ratio1.15%0.91%
Risk 5 year sharpe ratio-1.19--
Net assets$59.3M$140.2M
Average market cap----
Average P/E----
Dividend / Share--0.35%

Competitors

SH ProShares Short S&P500
SDS ProShares UltraShort S&P500
SPXU ProShares UltraPro Short S&P500

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
Holdings not available.

Partner Offers